Senior Director, Clinical Excellence Leader

Location
Allschwil
Workplace
On-site
Employment
Full-time

About this role

The Senior Director, Clinical Excellence Leader will play a critical leadership role in shaping and advancing clinical development best practices across the organization. This individual will drive harmonization of processes and standards across programs, ensure operational excellence in clinical trial execution, and support the development of a high-performance clinical development organization. The role requires deep expertise in global clinical development, strong leadership capabilities, and the ability to influence stakeholders across functions and levels.

Your tasks:

  • Lead harmonization of cross-study fit-for-purpose practices across development programs to elevate the quality and productivity of deliverables.

  • Drive the development, alignment, implementation, and continuous improvement of cross-functional clinical development processes and standards.

  • Serve as a role model and subject matter expert in the planning, execution, and delivery of complex global clinical trials, ensuring adherence to timelines, budgets, quality expectations, and regulatory requirements.

  • Identify operational risks and implement proactive mitigation strategies to support program success.

  • Foster a culture of excellence, collaboration, accountability, and continuous improvement across clinical development teams.

  • Partner closely with Clinical Operations, Clinical Science, Clinical Development, Biometrics, Regulatory Affairs, Quality Assurance, and other internal partners to optimize study execution and decision-making.

  • Contribute to organizational growth by supporting capability building, knowledge sharing, and process scalability.

Role requirements

  • Master's degree or equivalent university degree in Life Sciences, Healthcare, Pharmacy, or a related field.

  • Minimum of 15 years of clinical science and operational experience, including experience in early-phase clinical development.

  • Experience gained in both biotechnology companies and global drug development environments.

  • Demonstrated expertise in global clinical trial leadership, clinical data review and signal detection, project management, and risk management.

  • Strong understanding of the oncology drug development continuum from First-in-Human (FIH) through late-stage clinical development.

  • Proven ability to lead, influence, and align cross-functional teams in a dynamic environment.

  • Previous people leadership experience is advantageous.

  • Excellent communication, stakeholder management, and organizational skills.

  • Ability to thrive in a fast-paced, entrepreneurial, and rapidly evolving biotechnology environment.

Work permit

Candidate needs to hold a Swiss work permit or be an EU citizen eligible to work in Switzerland.

Apply to Alentis Therapeutics

Clera fills in Alentis Therapeutics's application for you.

How it works

Open the role in Clera

Sign in, and this role opens on your Clera job board, ready to apply.

Clera fills in the application

Clera fills the form from your profile and resume, and asks what's missing.

Track it in Clera

Each application you send shows up in your Clera tracker, sorted by stage.

Want Clera to find roles for you?

Ask your AI about this role

It knows you. Clera gives it the role.

Does this role fit my profile?

First time? Connect Clera once, about a minute.
One click above pre-fills the connector. Or by hand: Settings > Connectors > Add custom connector, paste https://mcp.getclera.com. Either way, sign in with the account you use on Clera and approve the consent screen.
https://mcp.getclera.com

Sign in with your Clera account. MCP docs

About Alentis Therapeutics

Alentis Therapeutics is a clinical-stage biotechnology company pioneering first-in-class antibody-drug conjugates (ADCs) and antibodies targeting Claudin-1 (CLDN1) for oncology and multi-organ fibrosis. CLDN1 is a previously unexploited target that plays a key role in the pathology of cancer and fibrotic disease. Alentis is the leading company pioneering CLDN1 ADCs and antibodies to modify and reverse the course of select diseases.

Alentis was founded based on ground-breaking research in the laboratory of Prof. Thomas Baumert, MD at the University of Strasbourg and the French National Institute of Health and Medical Research (Inserm). Alentis is headquartered at the pharma-biotech hub in Basel, Switzerland. Visit www.alentis.ch

Team size
51-200 employees people
Founded
2019
Industry
Pharmaceutical Manufacturing
Workplace
On-site
Locations
Allschwil, Basel-Landschaft, Switzerland